← Leaderboards
Edmond J Lavoie
Washington University
$1,087,778
Attributed
$1,087,778
Total exposure
9
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $240.8K · FY2005–11$250K$187.5K$125K$62.5K$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$1,087,778 · 9
By mechanism
R01$709,185 · 1
P41$378,593 · 8
Top collaborators
No co-investigators on record.
Most similar at Washington University
Same institution · by research overlap
- David F Wiemer$887,365
- Jonathan Edward McConathy$1,853,535
- Michael L Gross$20,301,359
- Alessandro Vindigni$5,609,059
- Eduardo A. Groisman$21,000,681
Others in their field
Top investigators on “Biomedical Resource”
- Eric S Lander · Whitehead Institute For Biomedical Res$327,348,429
- Richard A Gibbs · Baylor College Of Medicine$197,881,494
- Julianne L Imperato-McGinley · Weill Medical College Of Cornell Univ$159,861,320
- Ronald J Sokol · University Of Colorado Denver$154,805,139
- Steven M. Dubinett · Va Greater Los Angeles Healthcare System$154,215,387
- Joseph E Robertson · Oregon Health & Science University$128,745,682
Research focus
Biomedical ResourceUnited States National Institutes Of HealthMalignant NeoplasmsResourcesChemotherapeutic AgentGrantSourceFundingDesignLaboratoriesInstitutionInterestIsoenzymesLeadFutureAntitumor AgentPharmacologic SubstanceClinicBinding (Molecular Function)Computer Retrieval Of Information On Scientific Projects DatabaseCamptothecinResearch PersonnelG-QuartetsChemotherapy-Oncologic Procedure
Grant awards (14)
SYNTHESIS & EVAL OF 1,5,6 TRIAZACHRYSENE & 5,6,11 TRIAZACHRYSENE DERIVATIVES$2,241
P41 · FY2011 · RR · contact PI
SYNTHESIS & EVAL OF 1,5,6 TRIAZACHRYSENE & 5,6,11 TRIAZACHRYSENE DERIVATIVES$6,608
P41 · FY2010 · RR · contact PI
SYNTHESIS & EVAL OF 1,5,6 TRIAZACHRYSENE & 5,6,11 TRIAZACHRYSENE DERIVATIVES$7,092
P41 · FY2009 · RR · contact PI
SYNTHESIS & EVAL OF 1,5,6 TRIAZACHRYSENE & 5,6,11 TRIAZACHRYSENE DERIVATIVES$5,672
P41 · FY2008 · RR · contact PI
SYNTHESIS & EVAL OF 1,5,6 TRIAZACHRYSENE & 5,6,11 TRIAZACHRYSENE DERIVATIVES$5,536
P41 · FY2007 · RR · contact PI
Benzo[i]phenanthridines: TOP1-Targeting Antitumor Agents$226,964
R01 · FY2006 · CA · contact PI
SYNTHESIS & EVAL OF 1,5,6 TRIAZACHRYSENE & 5,6,11 TRIAZACHRYSENE DERIVATIVES$6,746
P41 · FY2006 · RR · contact PI
Benzo[i]phenanthridines: TOP1-Targeting Antitumor Agents$237,308
R01 · FY2005 · CA
SYNTHESIS &EVAL OF 1,5,6 TRIAZACHRYSENE &5,6,11 TRIAZACHRYSENE DERIVATIVES$3,537
P41 · FY2005 · RR
Benzo[i]phenanthridines: TOP1-Targeting Antitumor Agents$244,913
R01 · FY2004 · CA
SYNTHESIS &EVAL OF 1,5,6 TRIAZACHRYSENE &5,6,11 TRIAZACHRYSENE DERIVATIVES$17,878
P41 · FY2004 · RR
ENVIRONMENTAL POLYCYCLICS METABOLISM &ACTIVATION$157,506
P41 · FY2002 · RR
ENVIRONMENTAL POLYCYCLICS METABOLISM &ACTIVATION$157,506
P41 · FY2001 · RR
ENVIRONMENTAL POLYCYCLICS METABOLISM &ACTIVATION$8,271
P41 · FY2000 · RR